ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 643826 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 643826; 2) Community: the network communities that were significantly associated with the response to NSC 643826; 3) Molecule: the relationships between components within communities and NSC 643826; 4) MDR: the compounds that were significantly associated with the NSC 643826.

NSC Compound Enrichment Correlation
NSC 710549 Null 0.0105972823829604 0.40782719
NSC 722854 1,4-di-N-oxide-2-phenylcarbonyl-3-trifluoromethylquinoxaline 0.0105972823829604 0.28819039
NSC 737231 Null 0.0105972823829604 0.19392289
NSC 743876 Null 0.0105972823829604 0.33713993
NSC 747461 Null 0.0105972823829604 0.021898877
NSC 758881 Orlistat (USAN) 0.0105972823829604 0.36786
NSC 84074 Phosphonium, (3-bromopropyl)triphenyl- bromide 0.0105972823829604 0.20899232
NSC 622700 Methanaminium, (2-oxo-1,3-cyclohexanediyl)bis(methyl)bis [N,N,N-trimethyl-, diiodide 0.0119221520283057 0.014329107
NSC 669145 2-Butenoic acid, 2-methyl-, 2,3,3a,4,5,6,7,11a-octahydro- 6,10-dimethyl-3-methylene-2,7-dioxo-6,9-epoxycyclodeca[b]furan-4-yl ester, [3aR-[3aR*,4S*(Z),6R*,10Z,11aR*]]- 0.0119221520283057 0.074691107
NSC 339705 5H-Indeno[1,2-c]isoquinoline-5,11(6H)-dione, 6-(2-hydroxyethyl)- 0.0122129861493296 0.24431074
Total:77  Current:19    [First] [Prev] [Next] [Last]